P Lipponen

1.7k total citations
35 papers, 1.4k citations indexed

About

P Lipponen is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, P Lipponen has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 14 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in P Lipponen's work include Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (5 papers) and Prostate Cancer Treatment and Research (5 papers). P Lipponen is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (5 papers) and Prostate Cancer Treatment and Research (5 papers). P Lipponen collaborates with scholars based in Finland. P Lipponen's co-authors include Karí Syrjänen, S. Aaltomaa, E. Alhava, Markku Tammi, Raija Tammi, A. Siitonen, P. Helena Mäkelä, Ulla Kärkkäinen, V‐M Kosma and Kirsi Ropponen and has published in prestigious journals such as Clinical Infectious Diseases, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

P Lipponen

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Lipponen Finland 18 592 407 296 293 276 35 1.4k
Yoshitada Ohi Japan 19 578 1.0× 265 0.7× 257 0.9× 161 0.5× 209 0.8× 46 1.2k
Pavel Strnad Czechia 22 256 0.4× 435 1.1× 202 0.7× 155 0.5× 546 2.0× 70 1.7k
Naoya Takayama Japan 25 1.6k 2.8× 248 0.6× 323 1.1× 173 0.6× 90 0.3× 62 3.0k
Tze-Chein Wun United States 26 945 1.6× 451 1.1× 162 0.5× 1.8k 6.1× 95 0.3× 51 3.2k
Robin A. Pixley United States 26 493 0.8× 146 0.4× 105 0.4× 241 0.8× 107 0.4× 53 2.3k
Jeena Joseph India 17 722 1.2× 864 2.1× 131 0.4× 373 1.3× 108 0.4× 41 1.8k
V. Patel United States 20 798 1.3× 601 1.5× 126 0.4× 335 1.1× 156 0.6× 33 1.5k
Anna Maria Aglianò Italy 22 486 0.8× 654 1.6× 63 0.2× 330 1.1× 133 0.5× 43 1.3k
Shinichi Sasaki Japan 21 266 0.4× 297 0.7× 66 0.2× 101 0.3× 148 0.5× 81 1.2k

Countries citing papers authored by P Lipponen

Since Specialization
Citations

This map shows the geographic impact of P Lipponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Lipponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Lipponen more than expected).

Fields of papers citing papers by P Lipponen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Lipponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Lipponen. The network helps show where P Lipponen may publish in the future.

Co-authorship network of co-authors of P Lipponen

This figure shows the co-authorship network connecting the top 25 collaborators of P Lipponen. A scholar is included among the top collaborators of P Lipponen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Lipponen. P Lipponen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aaltomaa, S., et al.. (2002). Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer. Urologia Internationalis. 69(4). 266–272. 65 indexed citations
2.
Lipponen, P, et al.. (2001). Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.. PubMed. 21(4B). 3101–6. 78 indexed citations
3.
Aaltomaa, S., P Lipponen, Martti Ala‐Opas, et al.. (1999). Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. British Journal of Cancer. 80(12). 2001–2007. 70 indexed citations
4.
Ropponen, Kirsi, et al.. (1997). Comparison of classic and quantitative prognostic factors in colorectal cancer.. PubMed. 16(6B). 3875–82. 17 indexed citations
5.
Pirinen, Risto, P Lipponen, & Karí Syrjänen. (1996). Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.. PubMed. 15(6B). 2835–40. 14 indexed citations
6.
Siitonen, A., et al.. (1996). Recurrence of Urinary Tract Infection in a Primary Care Setting: Analysis of a I-Year Follow-up of 179 Women. Clinical Infectious Diseases. 22(1). 91–99. 281 indexed citations
7.
Kosma, V-M, et al.. (1996). Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. British Journal of Cancer. 74(5). 766–772. 79 indexed citations
8.
Auvinen, Päivi, P Lipponen, Risto Johansson, & Karí Syrjänen. (1996). Prognostic significance of TGF-beta 1 and TGF-beta 2 expressions in female breast cancer.. PubMed. 15(6B). 2627–31. 20 indexed citations
9.
Vesalainen, S., P Lipponen, Martti Talja, E. Alhava, & Karí Syrjänen. (1994). Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma.. PubMed. 14(2B). 709–14. 53 indexed citations
10.
Aaltomaa, S., P Lipponen, Veli‐Matti Kosma, et al.. (1993). Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer. The American Journal of Surgery. 165(3). 307–311. 7 indexed citations
11.
Aaltomaa, S., P Lipponen, M Eskelinen, et al.. (1993). Predictive Value of a Morphometric Prognostic Index in Female Breast Cancer. Oncology. 50(1). 57–62. 12 indexed citations
12.
Aaltomaa, S., P Lipponen, & Karí Syrjänen. (1993). Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.. PubMed. 13(2). 533–8. 45 indexed citations
13.
Aaltomaa, S., P Lipponen, M Eskelinen, et al.. (1992). Prognostic Factors after 5 Years Follow-Up in Female Breast Cancer. Oncology. 49(2). 93–98. 21 indexed citations
14.
Aaltomaa, S., P Lipponen, M Eskelinen, et al.. (1992). Tumor Size, Nuclear Morphometry, Mitotic Indices as Prognostic Factors in Axillary -Lymph-Node-Positive Breast Cancer. European Surgical Research. 24(3). 160–168. 13 indexed citations
15.
Lipponen, P, et al.. (1992). Mitotic indexes as prognostic predictors in female breast cancer. Journal of Cancer Research and Clinical Oncology. 118(1). 75–81. 43 indexed citations
16.
Tervahauta, Arja, et al.. (1992). Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.. PubMed. 11(5). 1677–81. 11 indexed citations
17.
Eskelinen, Matti, et al.. (1991). DNA Ploidy, S Phase Fraction and G2 Fraction asPrognostic Determinants in Prostatic Adenocarcinoma. European Urology. 20(1). 62–66. 14 indexed citations
18.
Lipponen, P, Matti Eskelinen, & Stig Nordling. (1991). Intratumoral Heterogeneity of DNA Indexes in TransitionalCell Bladder Cancer: Relation to Tumor Histology. European Urology. 20(4). 311–314. 11 indexed citations
19.
Lipponen, P, et al.. (1991). Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer. International Journal of Cancer. 49(6). 886–892. 41 indexed citations
20.
Eskelinen, Matti, P Lipponen, & Yrjö Collan. (1990). Immunohistochemical staining of human breast cancer with a new tumour marker MCA: relation to axillary lymph node involvement, metastasis, and survival.. PubMed. 10(3). 591–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitada Ohi Breakdown of academic impact, for papers by Pavel Strnad Breakdown of academic impact, for papers by Naoya Takayama Breakdown of academic impact, for papers by Tze-Chein Wun Breakdown of academic impact, for papers by Robin A. Pixley Breakdown of academic impact, for papers by Jeena Joseph Breakdown of academic impact, for papers by V. Patel Breakdown of academic impact, for papers by Anna Maria Aglianò Breakdown of academic impact, for papers by Shinichi Sasaki
Rankless by CCL
2026